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Genetic predisposition of otosclerosis has long been suspected, but unclarified. Unique coexpression pattern of measles virus
receptor (CD46) splicing isoforms in the human otic capsule is assumed, since otosclerosis is a measles virus-associated organ-
specific disease. In order to identify CD46 involved in the pathogenesis of otosclerosis, we used representative groups of
histologically diagnosed otosclerotic, nonotosclerotic, and normal stapes footplates (𝑛 = 109). Consecutive histopathological
examinations and CD46-specific Western blot analysis were performed. Normal and nonotosclerotic stapes footplates showed
consistent expression of the conventional c, d, e, f, and l CD46 isoforms. In contrast, four novel isoforms (os1–4) translated
as intact proteins were additionally detected in each otosclerotic specimen. The study herein presented provides evidence for
the otosclerosis-associated expression pattern of CD46. This finding might explain the organ-specific, virus-associated and
autoimmune-inflammatory pathogenesis of otosclerosis. Regarding our current knowledge, this is the first report that confirms
the presence of four new disease-specific protein variants of CD46.
1. Introduction
Otosclerosis is a complex inflammatory bone remodeling
disorder of the human otic capsule that leads to pro-
gressive conductive and/or sensorineural hearing loss as a
consequence of stapes footplate fixation and cochlear bone
resorption with endosteal involvement [1]. In the Caucasian
population, the prevalence of clinical otosclerosis is 0.3–0.4%
of the general population, 5–9% of those with hearing loss,
and 18–22% of those with conductive hearing loss [1, 2]. Silent
otosclerotic foci are more common: histological otosclerosis
without clinical symptoms has been reported as 8–11% in
large unselected autopsy series [2]. Otosclerotic foci are
limited to the temporal bone, and no lesions have been found
outside of the ear [2–5]. Otosclerosis takes approximately
two thirdS of stapes ankylosis cases leading to consecutive
conductive hearing loss [6]. Differential diagnosis is still
based on postoperative histological analysis of the removed
stapes footplates [3, 4, 7].
However, several hypotheses suggest viral, autoimmune,
and endocrine factors in the genesis of disease, etiopathogen-
esis of otosclerosis remained unexplained [3, 8–10]. Genetic
factors must play a significant role in the etiopathogenesis of
otosclerosis, although the precise mode of inheritance is still
uncertain [3, 5, 10]. The potential etiologic role of measles
virus in the pathogenesis of otosclerosis was suggested in
the past twenty-five years [8, 9]. The otosclerotic otic capsule
is assumed to exhibit a unique paramyxovirus favoring
receptor expression pattern, which could be the basis of the
pathogenesis of otosclerosis and also the reduced humoral
immune response against measles virus-derived antigens
[3, 6, 7].
One of the human cellular receptors for measles virus is
the CD46 molecule, also known as membrane cofactor pro-
tein (MCP) [11]. CD46 has a cofactor activity for inactivation
of complement components C3b and C4b by serum factor I,
which protects the host cell from damage by the complement
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system [11]. Signals mediated by CD46 have a great influence
on T-cell activation [11, 12]. Beyond these functions, CD46
plays a role in the pathogenesis of various inflammatory
disorders. Its therapeutic potential in inflammatory diseases
has also been suggested. Elevated serum levels of CD46
have been reported in systemic lupus erythematosus (SLE)
[13]. Recombinant soluble CD46 has been introduced to
animal models of various inflammatory diseases [14]. For
example, CD46 treatment inhibited acute cardiac transplant
rejection [14]. Accordingly, targeted therapies using recom-
binant CD46 may be useful in autoimmune-inflammatory
conditions [3, 14]. The mRNA of CD46 is translated from
a single gene linked to chromosome 1q32; however, it is
posttranslationally modified by alternative splicing resulting
in 14 known splicing variants and corresponding protein
isoforms [6, 11, 12]. Different numbers of CD46 isoforms are
coexpressed by all nucleated human cells in various patterns
[11]. However, specific functions have not been associated
to isoform coexpression yet [6, 11]. In 2008, Karosi et al.
described four novel otosclerosis-associated splicing variants
of CD46 mRNA; however, no additional reports have arisen
about the translated and corresponding protein isoforms
associated to the etiopathogenesis of otosclerosis [6].
The present study investigates the coexpression pattern of
CD46 protein isoforms in histologically proven otosclerotic,
nonotosclerotic, and normal stapes footplates in order to
establish organ-specific, otosclerosis-associated alternative
splicing of the measles virus receptor CD46.
2. Materials and Methods
2.1. Patients and Controls. Altogether 109 stapes footplates
(male = 39, female = 70) were analyzed. Out of these samples,
92 were ankylotic and removed by stapedectomy and were
immediately fixed in 10% (w/v) formaldehyde. The mean age
of patients was 41.7 years (range: 21–72 years). Stapes footplate
specimens were selected histologically from a larger pool
(𝑛 = 419) of ankylotic stapes samples with the aim of obtain-
ing representative groups of otosclerotic and nonotosclerotic
stapes footplates. Partially removed stapes footplates were
not included in the study because the anterior or posterior
poles containing the bone lesions fixing the stapes were
retained in the oval window niche. However, fragmented and
reconstructed footplates were not excluded. The diagnosis of
ossicular chain fixation was based on clinical, audiometric,
and tympanometric findings. Air-bone gap at 1000Hz was
at least 30 dB. Preoperative tympanometry revealed type-
As tympanograms in 67.4% and type-A tympanograms in
32.6% of stapes fixation cases. High resolution CT scan was
performed in 18 cases that revealed thickening of the stapes
footplate in 11 cases with no apparent signs of hypoden-
sity due to otosclerotic foci in the otic capsule or in the
stapes footplate. Seventeen cadaver stapes specimens with
negative otopathological history were removed by dissection
of temporal bones and were employed as negative controls
(𝑛 = 17, male = 8, female = 9).These were removed within 20
hours after death.The mean age of negative controls was 53.5
years (range: 49–69 years). Stapes footplates were collected
between January 2008 and March 2009 at the Universities
of Debrecen, Pe´cs and Szeged, and at the Department of
Otolaryngology, Bajcsy-Zsilinszky Hospital, Budapest, Hun-
gary. We obtained Hungarian Scientific Research Ethical
Committee (ETT-TUKEB/2008) and Institutional Ethical
Committee (DE OEC-EB/2008/12) approvals. The study was
carried out according to the Declaration of Helsinki.
2.2. Histopathological Analysis. A total of 109 stapes footplate
specimens were fixed in 10% (w/v) formaldehyde and decalci-
fied in 0.5MNa-EDTA containing 0.02% (w/v) sodium azide
(72 h, 4∘C). Specimens were embedded in 15% (w/v) purified
gelatin (24 h, 56∘C) and refixed in 4% (w/v) paraformalde-
hyde (24 h, 20∘C). Blocks were cryoprotected in 20% (w/v)
saccharose solution (2 h, 4∘C) and sectioned into 10 𝜇m
slides at −25∘C (MNT-200, Slee, Mainz, Germany). Slides
were stored in 0.1M PBS containing 0.03% (w/v) sodium
azide at 4∘C. Two consecutive 10 𝜇m frozen cut “swimming”
sections were examined as follows: (1) conventional staining
with hematoxylin and eosin (H&E); (2) pooling and CD46-
specific Western blot analysis. Active and inactive otosclero-
sis cases were differentiated by phase-contrast microscopy.
Histological examinations were blinded for two indepen-
dent researchers: Cs.P. analyzed the sections stained by
H&E, while T.K. reviewed the preliminary histopathological
diagnosis.
2.3. CD46-Specific Western Blot. Second series of the histo-
logically analyzed stapes footplates (𝑛 = 109) was recruited
into three pooled groups: otosclerosis (𝑛 = 50), nono-
tosclerotic stapes fixation (𝑛 = 42), and normal stapes
footplates (𝑛 = 17). Pooled specimens were rinsed three
times with sterile PBS buffer to remove contaminants and
then ground into powder in liquid nitrogen. Samples were
lysed in RIPA buffer (150mM NaCl, and 1% [w/v] NP40,
50mMTris-HCl, 5% [w/v] Na-deoxycholate, 0.1% [w/v] SDS,
[w/v] 0.01% sodium-azide, 1mM EDTA) supplemented with
Complete EDTA-free Protease Inhibitor Cocktail (Roche,
Basel, Switzerland). The protein concentration was deter-
mined using Bradford assay. Total protein extracts (10–
15 𝜇g) were boiled in SDS loading buffer and separated in
a 7% (w/v) SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) and electroblotted onto a nitrocellulose membrane.
Membrane was blocked in 5% (w/v) skim milk powder in
Tris-buffered saline Tween (TBST: 10mMTris, 150mMNaCl,
0.05% [w/v] Tween20; pH = 7.9), and proteins were detected
with anti-CD46 (1 : 200; R&D Systems, Minneapolis, MN,
USA) and anti-𝛽-actin (1 : 1000; Sigma-Aldrich, Deisenhofen,
Germany) antibodies in 5% (w/v) skimmilk powder in TBST.
The blot was washed three times with TBST, incubated with
horseradish peroxidase (HRP)-labeled secondary donkey
anti-goat (R&D Systems, Minneapolis, MN, USA) and goat
anti-rabbit (Santa Cruz, Santa Cruz, CA, USA) antibody at a
dilution of 1 : 1000, washed and visualized with Super Signal
West Pico Chemiluminescent Substrate (Pierce, Rockford,
IL, USA), and exposed to X-ray film (Kodak, London, UK).
THP-1, C33A, and HeLa cell lines were used as positive
controls of CD46-specific western blot.
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Figure 1: Representative histological findings of ankylotic and normal stapes footplates (H&E). (a) Obliterative otosclerosis with high activity
at the anterior pole of the stapes footplate. Hypercellularity and increased numbers of osteoclasts should be noted. “Swiss cheese” pattern of
pseudovascular spaces is marked by the white arrow. (b) Inactive otosclerotic focus at the anterior pole of the stapes footplate. Hypocellularity,
hypovascularization, marked basophilia, and woven pattern of cement lines can be considered. (c) Hemosiderosis with pathological bone
remodeling and active eosinophilic staining. The osteocytes of the stapes footplate are absent and are replaced by hemosiderophages
containing dark hemosiderin granules. (d) Annular calcification with decreased cellularity and vascularization. The stapes footplate shows a
marked thickening and an angled, bulky posterior pole (black arrow). (e) Histological representation of a normal stapes. Abbreviations: AP:
anterior pole; PP: posterior pole; AC: anterior crus; PC: posterior crus; FP: footplate.
3. Results
Histological diagnosis of otosclerosis was established in 50
ankylotic stapes footplates (Figure 1). According to phase
contrast microscopic analysis, otosclerotic foci were seen to
be active in 37 stapes footplates and inactive in 13 cases
(Figure 1). Active otosclerosis was featured by thickened, and
distorted stapes footplate with irregular, woven pattern of
cement lines.The focus of otosclerosis was basophilic, hyper-
vascularized and filled with numerous multinucleated osteo-
clasts, hypercellular fibrous stroma and plump, and distorted
osteoblasts (Figure 1). Inactive otosclerosis was characterized
by predominantly eosinophilic, woven bone containing some
lamellar structure. Osteoclasts and osteoblasts were vanished;
vascular spaces were eventually obliterated (Figure 1). In the
42 nonotosclerotic stapes footplates, histological examina-
tions revealed annular calcification with eosinophilic extra-
cellularmatrix, decreased cellularity and hypovascularization
(𝑛 = 39), and hemosiderosis with intense bone remodeling of
the stapes footplate (𝑛 = 3) (Figure 1).
Conventionally translated isoforms [c (89 kDa), d
(78 kDa), e (61 kDa), f (51 kDa), and l (37 kDa)] of CD46
were detected by western blot analysis of normal and nono-
tosclerotic stapes footplates (𝑛 = 59) (Figure 2). As compared
to these specimens, in otosclerosis (𝑛 = 50), four additional
protein bands of CD46 isoforms were identified: os1, os2, os3,
and os4 (27 kDa, 20 kDa, 17 kDa, and 14 kDa, resp.) (Figure 2).
The estimatedmolecular weights of os1–4 isoforms correlated
with the mRNA sequence of otosclerosis-associated CD46
splicing variants reported earlier [6]. Coexpression of novel
os1, os2, os3, and os4 CD46 protein isoforms was exclusively
associated to the histological diagnosis of otosclerosis in the
ankylotic stapes footplates.
4. Discussion
Genetic predisposition for otosclerosis has long been dis-
puted over the last decades, without obvious target genes or
mutations to show up [3, 10, 15]. Several studies have reported
genetic associations in populations with clinical otosclerosis
without histopathological confirmation and have extrapo-
lated the observations to otosclerosis irrespective nonoto-
sclerotic fixations [10, 15]. The majority of genetic studies
on families with stapes fixation and on large unselected
populations has suggested an autosomal dominant mode
of inheritance with incomplete penetrance of approximately
40–45% [10, 15]. Genetic linkage studies have demonstrated
the presence of eight loci (OTSC1-8) located on chromosomes
15q, 7q, 6p, 16q, 3q, 6q, and 9p, respectively [3, 10, 15].
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Figure 2: Western blot analysis of CD46 expression pattern in stapes footplate pools with different histopathologies. As controls of CD46
expression and western blot procedure, THP-1, C33A, and HeLa cell lines are characterized by exclusive expression of variant f (THP-1,
C33A) and coexpression of variants f and g (HeLa), respectively. Beta-actin was used as the housekeeping control of CD46 coexpression
in each stapes footplate pools. At the final level of protein expression, normal, and nonotosclerotic stapes footplates are featured by
coexpression of c, d, e, f, and l isoforms. In contrast, histologically otosclerotic stapes footplates express further four novel protein isoforms of
CD46 (os1–4). Exact molecular weights of os isoforms were calculated by ProteinCalculator (v3.3) online software (http://www.scripps.edu/
∼cdputnam/protcalc.html).
Although these loci have been mapped, no causative genes
and proteins have been identified and we have a little idea
of the molecular process involved in this disease [3, 10, 15].
It has been reported that COL1A1, BMP2, BMP4, TGFB1,
and RELN genes may also contribute to the development
of otosclerosis [16–19]. Furthermore, prior associations with
these genes account for only a small fraction of the relative
risk for otosclerosis or other types of stapes fixation [16–
19].These associations reported earlier cannot explain female
dominancy, adult onset, organ specificity, and the inflamma-
tory bone remodeling disorder, all characteristic features of
otosclerosis [3, 4]. As to previous results, average life span
of an active otosclerotic focus is about 5 to 7 years until
inactivation; hence a dynamic genetic hypothesis is necessary
to explain this “healing” process [20]. The involvement of
T-cells, inflammatory cytokines, and other mediators in
otosclerosis suggest an autoimmune-inflammatory nature of
the disease [3, 20].
No animal model exists for the otosclerotic bone remod-
eling disorder, which is associated to the presence of measles
virus in the foci [3, 4]. Measles virus is found exclusively in
otosclerotic bone in human [8, 9]. This called the attention
to the CD46 molecule, which is not expressed as virus
receptor in other mammalian species, except humans [6, 11,
12]. Specific diseases have not yet been attributed to CD46
isoform coexpression; however, present study supplies essen-
tial information about novel translated isoforms of CD46
emphasizing a potential association between isoform coex-
pression and otosclerosis.
Various expressions of different splicing variants of CD46
seem to be one of the acceptable explanations for the genetic
background of otosclerosis [6]. Newly described CD46 pro-
tein isoforms have a shorter or missing transmembrane and
uncommon cytoplasmic domains; however, virus-binding
domain remains conservative (Figure 3). Transmembrane
and soluble isoforms of CD46 protein have been identified
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Figure 3: Schematic structure of a conventional and the four otosclerosis-associated CD46 protein variants. Abbreviations: N-N: terminal
of CD46; C-C: terminal of CD46; CCP: complement control protein region; SCR-1 and SCR-2: short consensus repeats 1 and 2; STP-Serine:
threonine-proline rich region; U: region of unknown significance; TM: transmembrane domain; CYT2 and CYT3: cytoplasmic domain 2
and 3.
in humans and transgenic mice [6, 11, 12]. In mice, there
is an exon spliced alternatively, which allows the encoding
of a soluble, cytoplasmic isoform [6, 11]. Although soluble
isoforms of human CD46 have been found in different body
fluids, mRNA encoding soluble forms remain unidentified
until now [11]. The present study supplies direct evidence of
a human soluble CD46 isoform (os4) produced by alternative
splicing (Figures 2-3). These changes should result in func-
tional consequences of signaling that may be responsible for
the persisting replication of measles virus.
Decreased serum level of anti-measles IgG is character-
istic for otosclerosis, which is independent from vaccination
or measles virus infection and can be determined by expres-
sion of otosclerosis-associated CD46 isoforms [6, 7]. Newly
described isoforms are supposed to allow virus internal-
ization without TCR-dependent activation of primary CD4
positive T-helper cells and consecutive induction of B-cell-
dependent immunoglobulin production [6, 7, 11, 12]. It is
supposed that the most important factor in the pathogenesis
of otosclerosis is a consecutive autoimmune reaction due
to continuous CD46-presented viral antigen stimulation of
natural killer cells and CD8 positive T-lymphocytes [6, 11, 12].
Several inflammatory cytokines (TNF-alpha, IL-1, and TGF-
beta) and bone-specific proteins (osteoprotegerin, BMP)
also may play a secondary promoting role in this process
[4, 17, 18, 20].
Proteins expressed as different splicing isoforms are able
to imitate regularMendelian inheritance [3, 6, 10, 11]. Familial
cases of otosclerosis showing obscure autosomal dominant
inheritance with incomplete penetrance might be considered
as a common disease caused by unique alternative splicing
of measles virus receptors in the otic capsule [10, 15]. An
unresolved question is whether measles virus can induce the
expression of new CD46 splicing variants, or existing novel
isoforms lead to the increased virus affinity and smooth virus
replication [6, 11, 12]? The answer may hide in the expression
of different regulatory proteins of alternative splicing leading
to a special expression pattern and altered functions of CD46
that could explain the organ-specific and virus-associated
pathogenesis of otosclerosis [4, 6, 11, 12].
In conclusion, we found a strong association between the
expression of novel CD46 protein isoforms and histologi-
cally confirmed otosclerosis. Our results are consistent with
four new splicing variants of CD46 mRNA being causally
related to the viral pathogenesis of otosclerosis [6]. Special
expression pattern of CD46 isoforms due to organ-specific
alternative splicing may explain genetically determined sus-
ceptibility for persisting measles virus infection observed
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in otosclerosis. In contrast to these observations, in the future,
further molecular biological research will be necessary to
confirm or exclude our results in the genetic predisposition
of otosclerotic bone remodeling disorder.
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